Skip to content

AMPIO PHARMACEUTICALS, INC.

CIK 0001411906

← back to feed
Revenue (TTM)
$714.68K
−3.7% YoY FY Mar 2024
Net Income (TTM)
−$12.99M
+47.2% YoY FY Mar 2024
EPS Diluted (TTM)
−$11.94
+63.6% YoY FY Mar 2024
Gross Margin
65.8%
FY Mar 2024
Operating Margin
-4,659.7%
FY Mar 2024
Net Margin
-1,817.5%
FY Mar 2024
Free Cash Flow (TTM)
−$16.03M
FY Mar 2024
Cash
$4.09M
FY Mar 2024
Total Debt
—
FY Mar 2024
Shares Outstanding
1.14M sh
FY Mar 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings